Skip to main content

Table 4 Injection information

From: Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont

Variable

All participants

(n = 90)

Stimulants main drug

(n = 32)

Opioids main drug

(n = 44)

Stimulants and opioids main drug

(n = 12)

M

Range

M

Range

M

Range

M

Range

# Other people getting syringes for

0.85

0–10

.88

0–10

0.95

0–5

0.58

0–2

# Days syringes picked up in past month

4.70

0–30

4.88

0–30

4.77

0–30

4.58

0–15

Age of first injection of any drug

22.95

9–46

24.61

9–46

21.40

13–41

22.50

15–33

Years since initiating injecting

14.81

0–49

16.19

0–49

15.23

0–43

13.73

7–21

# Days injected in past week

5.34

0–7

4.66

0–7

5.71

0–7

6.33

2–7

# Injections per day

5.43

1–20

4.21

1–10

5.49

1–20

7.82

3–20

# Times syringe used before discard

1.85

1–27

2.21

1–27

1.57

1–6

2.25

1–10

 

N

%

N

%

N

%

N

%

Frequency of being alone when injecting

Never

38

42.2

11

34.4

18

40.9

8

66.7

Sometimes

27

30.0

10

31.3

14

31.8

3

25.0

Most times

19

21.1

6

18.8

11

25.0

1

8.3

Always

6

6.7

5

15.6

1

2.3

0

0

Frequency of injecting in public

89

   

43

   

Never

34

38.2

17

53.1

12

27.9

4

33.3

Sometimes

34

38.2

10

31.3

19

44.2

5

41.7

Most times

14

15.7

2

6.3

8

18.6

3

25.0

Always

7

7.9

3

9.4

4

9.3

0

0

Injection-related health

Abscess or skin infection

39

43.3

9

28.1

25

56.8

5

41.7

Blood clot or blood infection

11

12.2

4

12.5

5

11.4

2

16.7

Endocarditis

5

5.6

1

3.1

4

9.1

0

0